Clinical Trials Logo

Clinical Trial Summary

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03872401
Study type Interventional
Source Amgen
Contact
Status Active, not recruiting
Phase Phase 3
Start date June 11, 2019
Completion date July 26, 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT01631409 - Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy N/A
Completed NCT04610892 - Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction Phase 2
Recruiting NCT05834673 - VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) Phase 4
Completed NCT00685776 - Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019) Phase 3
Completed NCT03427489 - A Biorepository for Coronary Heart Disease in Qatar
Active, not recruiting NCT01864031 - The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study N/A
Not yet recruiting NCT05178602 - The Effect of TaiChi on Ischemic Burden of Patients With Coronary Heart Disease Complicated With Renal Insufficiency N/A
Not yet recruiting NCT06216847 - Clinical Outcomes of Patients With Coronary Artery Disease
Recruiting NCT06170541 - CORE-COMPARE Pilot Study N/A
Recruiting NCT01315834 - Couples Coping With Coronary Heart Disease N/A